Genmab reported DKK465M in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Agios Pharmaceuticals AGIO:US $ -94.63M 5.86M
AstraZeneca AZN:LN -347M 1305M
Bayer BAYN:GR € 1161M 1076M
Fresenius Medical Care FME:GR € 229M 44M
Genmab GEN:DC DK 465M 251M
GRIFOLS GRF:SM € 136.88M 6.94M
Hikma Pharmaceutical HIK:LN 173M 75M
Immunogen IMGN:US $ -24.14M 13.03M
Lonza Group LONN:SW 2.62B 2.31B
Novartis NOVN:VX SF 16308M 13550M
William Demant Holding WDH:DC 1.34B 165M